NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ascilion AB

Ascilion AB

Private
KistaHealthcare & Life Scienceshttps://www.ascilion.com/

Last Round

Series A

Sep 22, 2025

Total Funding Raised

$2.85M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ascilion AB is a medtech company that has developed a microneedle technology platform for the painless extraction of dermal interstitial fluid for diagnostics and health monitoring.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Sensors, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Infrastructure

Keywords

dISF samplinghollow microneedlesminimally invasive samplingmicroneedle technologymicroneedle patchbiomarker monitoringdermal interstitial fluidbiomarker accesspainless samplingliquid biopsywearable sensorsblood draw alternativedrug development toolsbiosensor platformcosmetic testingclinical trial toolsMEMS manufacturingprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ascilion AB Comps

Public and private peers based on sector, stage, and business model.

Ascilion AB comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ascilion AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 22, 2025
SeedJan 3, 2022
GrantJan 1, 2021
View all Funding Rounds

Key People

Founding team and executive leadership

Pelle Rangsten

Co-founder & CTO

Founding Team

Ascilion AB Investors

Notable investors and investment history

Ascilion AB investors
InvestorRounds
NordstjernanSeed
European CommissionGrant
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2026

    Grew 30% QoQ, from 10 to 13 employees.

  • Feb 25, 2026

    Grew 83% QoQ from 6 to 11 employees.

View all signals

Ascilion AB Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ascilion AB Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ascilion AB's valuation, stock price, and market status.

Firmographic Details

HeadquartersKista
Employee Range13
Year Founded2012
Last FundingSep 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.